Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

HOWLHOWL
13 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in WEREWOLF THERAPEUTICS INC

CITADEL ADVISORS LLC previously held 0 shares of HOWL (WEREWOLF THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$89,000

Total Shares Change

-20,144

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.36
0
2026-Q1
New
10,382
-
$8,6440.0%$0.59
25
2025-Q4
Exited
0
-100.0%
$00.0%$0.61
0
2025-Q3
New
154,534
-
$304,4320.0%$2.19
36
2024-Q4
Exited
0
-100.0%
$00.0%$1.48
0
2024-Q3
Decreased
11,507
-82.0%
$24,3950.0%$2.12
0
2024-Q2
Increased
63,954
+1981.2%
$156,0480.0%$2.44
25
2024-Q1
Decreased
3,073
-85.7%
$19,9130.0%$6.48
0
2023-Q4
New
21,522
-
$83,0750.0%$3.86
33
2023-Q1
Exited
0
-100.0%
$00.0%$2.59
0
2022-Q4
New
11,030
-
$22,6110.0%$2.05
29
2022-Q2
Exited
0
-100.0%
$00.0%$3.88
0
2022-Q1
New
20,144
-
$89,0000.0%$4.13
33

Other major holders of HOWL: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used